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INTRODUCTION
Congenital anomalies are considered increasingly important in 
public health due to the associated high morbidity and mortality ra-
tes(1). In most cases, the cause is presumably multifactorial(2-4). Terato-
gens are associated with 2% to 10% of cases(2,3). Sociocultural factors 
in developing countries favor increased exposures to teratogens(5,6). 
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Society. This cross-section comprised 41 patients (age, mean ± standard deviation, 
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Patients underwent ophthalmological assessments. They were subdivided into 
groups according to misoprostol exposure during pregnancy, and the two groups 
were compared. 
Results: Mothers/caregivers reported unplanned pregnancies in 36 (88%) cases. 
Of these, 19 (53%) used misoprostol during their first trimesters. A stable marital 
status tended to be more frequent in the unexposed group (P=0.051). Incomplete 
elementary school education was reported by two (11%) mothers in the exposed 
group and by three (14%) mothers in the unexposed group (P=0.538). The mothers’ 
gestational exposures to cocaine, marijuana, alcohol, and cigarettes were similar 
in both groups (P=0.297, P=0.297, P=0.428, and P=0.444, respectively). One (5%) 
case of Rubella infection during pregnancy was found in the unexposed group. 
The main malformations in the exposed and unexposed groups were the following: 
strabismus (72% and 77%, respectively), lack of emotional tearing (47% and 36%, 
respectively), and lagophthalmos (32% and 41%, respectively). 
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RESUMO
Objetivo: Descrever o perfil sóciodemográfico, exposição à teratógenos e anormali ­
dades oculares congênitas em pacientes brasileiros portadores da sequência de 
Möbius. 
Método: Quarenta e quatro pacientes recrutados da Sociedade Brasileira de Se­
quência de Möbius foram examinados. Este estudo transversal incluiu 41 pacientes 
que preencheram os critérios de inclusão do estudo (média das idades: 9,0 ± 5,5 anos). 
Mãe/responsável dos pacientes responderam a um questionário sobre perfil sóciode­
mográfico e história gestacional. Foi realizado exame oftalmológico de todos os 
pacientes. Eles foram agrupados em dois grupos de acordo com a exposição ao 
misoprostol durante a gestação e seus dados foram comparados. 
Resultados: Mães/responsáveis referiram gravidez indesejada em 36 (88%) dos 
casos. Destas, 19 (53%) fizeram uso de misoprostol no primeiro trimestre de gestação. 
Houve uma tendência do grupo de mães não expostas ao misoprostol de terem um 
estado civil estável (P=0,051). Duas (11%) mães do grupo de expostas ao misoprostol 
relataram primeiro grau incompleto e três (14%) do grupo de não expostas (P=0,538). 
A exposição das mães à cocaína, maconha, álcool e cigarro foi similar em ambos os 
grupos (P=0,297, P=0,297, P=0,428, P=0,444, respectivamente). Houve um caso (5%) 
de Rubéola no grupo de mães não expostas. As principais malformações associadas 
nos pacientes expostos e não expostos foram, respectivamente: estrabismo (72% e 
77%), e diminuição da lágrima emocional (47% e 36%) e lagoftalmia (32% and 41%). 
Conclusão: Estado civil estável foi mais frequente em mães que não fizeram uso de 
misoprostol durante a gestação. Exposição à outros teratógenos e malformações 
oculares tiveram distribuição semelhante em ambos os grupos. 
Descritores: Síndrome de Möbius/fisiopatologia; Teratogenios; Anormalidades con gê­
nitas/etiologia; Misoprostol/efeitos adversos; Complicações na gravidez
The use of abortive medications, such as misoprostol and certain her-
bal teas, are common in these countries(7,8) and are associated with 
congenital anomalies(7,9-11). 
Möbius sequence is a rare congenital disorder with an estima-
ted prevalence in the general population of 1:500 to 1:5,000 new-
borns(7,12). Although most cases are sporadic and some have been re-
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lated to genetic mutations(13-15), intrauterine exposure to misoprostol 
and other teratogens has been associated with its occurrence(16-21). 
The aim of the present study was to report the sociodemographic 
profiles, teratogen exposures, and congenital abnormalities in pa-
tients with Möbius sequence. 
METHODS
This cross-sectional study followed the tenets of the Declaration 
of Helsinki and was approved by the Ethics Committee on Human 
Research of the Santa Casa de Misericórdia of São Paulo. Each pa-
tient and/or caregiver gave written informed consent before being 
included in the study. The data used in this study were collected by a 
multidisciplinary team from several institutions from North America 
(University of Illinois, Chicago) and Brazil [Altino Ventura Foundation 
and Hospital de Olhos de Pernambuco in Recife; as well as College of 
Medical Sciences of Santa Casa of São Paulo; Federal University of São 
Paulo (UNIFESP); University of São Paulo (USP); Disabled Children 
Assistance Association (AACD); Epileptic Children Psychiatry Assistan-
ce Group; and Cema Institute, in São Paulo. 
The Brazilian Möbius Syndrome Society is an association in sou-
theastern Brazil for patients with Möbius sequence. The patients were 
recruited by telephone, email, or fax, and 44 patients were assessed 
in two consecutive days at the Department of Ophthalmology of the 
College of Medical Science of Santa Casa of São Paulo. A standardized 
questionnaire was used to collect the sociodemographic data and 
the pregnancy histories from the parents or caregivers. The following 
main variables were assessed: expected/unexpected pregnancy, 
mother’s marital status at the time of the pregnancy, education (ma-
ximum education achieved by the mother at the time of pregnancy), 
symptoms during pregnancy, and exposure to medications, such as 
misoprostol and/or other teratogens. 
The inclusion criteria were uni-orbi-lateral congenital sixth and 
seventh nerve paralysis(7). Poland-Möbius sequence was defined as 
the association of Möbius sequence with unilateral aplasia of the 
pec toralis major muscle and an ipsilateral hand anomaly(18). 
The patients(13) underwent a multidisciplinary assessment that 
consis ted of clinical, ophthalmological, neurological, genetic, psy-
chia tric, psychological, and dental examinations. In the present study, 
we describe the mothers’ sociodemographic data and the patients’ 
congenital ocular malformations (strabismus, lagophthalmos, aber-
rant tearing, and lack of emotional tearing). 
The ophthalmological assessment included evaluations of eye 
alignment, movement limitations, eyelid positions, and lacrimal al -
te rations. The strabismus was classified as convergent (esotropia), 
di vergent (exotropia), or vertical (hyper-or hypo-tropia). Congenital 
aberrant tearing was considered in cases presenting paradoxical 
gustolacrimal tearing (tearing when eating or crocodile tears), lack of 
emotional (psychic) lacrimation, or unusual late onset of tearing(22). 
Late onset of tearing was defined in this study as tearing that started 
after the patient was 1 year old(23-25). 
For comparison, patients were divided into two groups according 
to misoprostol exposure during pregnancy. Statistical analyses were 
performed with SPSS for Windows (version 12.0, IBM Corporation, Ar-
monk, NY, USA). Continuous data were expressed by mean ± standard 
deviation (SD), and categorical data were expressed as percentages. 
Chi-square and Student’s t-tests were used to compare the groups 
that were exposed or not exposed to misoprostol or to other terato-
gens. P values less than 0.05 were considered statistically significant.
RESULTS
Forty-one patients met the inclusion criteria and were enrolled 
in the study. Their mean ± standard deviation (SD) age was 9.0 ± 5.5 
years (range, 2 to 22 years), and 24 (59%) were male. Nineteen (46%) 
patients had a history of intrauterine misoprostol exposure. Of these, 
13 (68.4%) patients were male, and the mean ± SD age of the group 
was 9.1 ± 4.8 (range, 3 to 22 years). Similarly, 11 (50%) of the 22 pa -
tients with no history of misoprostol exposure during pregnancy 
were male (P=0.381), and the mean ± SD age of the group was 8.9 ± 6.1 
(range, 2 to 21 years).
Thirty-five (85%) mothers denied previous abortions, three (7%) 
reported a previous induced abortion, and three (7%) had a previous 
miscarriage. Thirty-six (88%) mothers reported that the pregnancy 
with their son/daughter who was included in the study was not 
planned. Of these, 20 (56%) admitted to thinking about abortion, 
and 19 (53%) used misoprostol as an abortifacient during the first 
trimester. Eleven (84%) of these 19 women used oral and vaginal 
pills, and two (15%) only took oral pills. Six (32%) caregivers did not 
know which misoprostol route of administration was used by the 
mother nor the number of pills taken. The average ± SD amount of 
pills administered orally was 2.2 ± 0.5 pills (range, 1-8 pills), and the 
average ± SD administered vaginally was 2.1 ± 0.3 pills (range, 1-4 
pills). The average ± SD time of administration after fertilization was 
7.0 ± 1.2 weeks (range, 2-14 weeks). After misoprostol administration, 
five (39%) mothers had cramps, and four (31%) presented bleeding, 
although none were hospitalized.
The mothers’ mean ± SD age at the time of pregnancy was 24.3 
± 4.9 years (range, 16 to 35 years). The mean ± SD age of the mothers 
who used misoprostol was 23.5 ± 4.7 years (range, 17 to 33 years), and 
that of the mothers that did not use the drug was 25.0 ± 5.2 years 
(range, 16 to 35; P=0.351). A stable marital status was reported by four 
(25%) of the mothers that used misoprostol and by 13 (62%) of the 
mothers that did not use misoprostol (P=0.051) (Table 1). 
The mothers’ highest educational levels at the time of pregnancy 
in both groups were not significantly different (P=0.538) (Table 2). 
Thirty-four (87%) mothers reported specific symptoms during 
their pregnancy. The main symptoms were nausea (56%), heartburn 
(59%), and vomiting (46%) (Table 3).
Twenty-three (56%) of the 41 mothers in the study were exposed 
to a teratogen during pregnancy; four (10%) were from the unex-
posed to misoprostol group, and 19 (46%) were from the exposed 
group. In the exposed group, four (21%) were associated with other 
teratogen(s) during pregnancy. In two (5%) cases, the mothers used 
misoprostol, cocaine, cigarettes, and marijuana. Nevertheless, the 
distributions of teratogens (rubella, cocaine, marijuana, cigarettes, 
and alcohol) were similar in both groups (P=0.537, P=0.209, P=0.209, 
P=0.444, and P=0.428, respectively) (Table 4).
In all 41 patients, the main congenital malformations that were 
found were strabismus, lack of emotional tearing, and lagophthal-
mos, with similar distributions between the two groups (P=0.387, 
P=0.693, and P=0.769, respectively) (Table 4). Of the patients with 
strabismus, 24 (80%) had esotropia. One (5%) patient in the exposed 
group presented Duane syndrome, and another case (5%) presented 
esotropia that was associated with Poland-Mobius sequence. This 
last patient had been previously treated for a corneal ulcer. Two (9%) 
of the unexposed patients presented concomitant third nerve palsy 
and exotropia.
There was aberrant tearing when eating (crocodile tears) in 12 
(29%) patients from both groups, with five (42%) unilateral and seven 
(58%) bilateral. The absence of emotional tears was seen in 17 (42%) 
patients, and late-onset tearing was seen in 13 (33%). An increased 
pattern of spontaneous tearing was reported in seven (17%) patients 
from both groups.
DISCUSSION
Teratogens are factors that are external to the fetal genome that 
induce structural and functional disturbances during prenatal deve-
lopment. External factors, including medications, are responsible for 
5% of congenital malformations(1,6,26). In unexpected pregnancies, the 
risk of exposure to teratogens is higher(2,4). In North America, 50% of all 
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pregnancies are unexpected or unplanned, and, in Brazil, a previous 
study reported that 48% of pregnant women between the ages of 18 
and 39 use abortifacient drugs(3,27). Misoprostol is the main method 
(94%) used to induce illegal abortions among adolescents in the 
State of Piauí (northeastern Brazil), and this drug was associated with 
herbal tea in one case(11). In the current study, the majority of mothers 
(90.2%) of patients with Möbius sequence reported an unplanned 
pregnancy. Of these, 48.8% considered terminating the pregnancy, 
and 46.3% used misoprostol as an abortifacient drug. Two patients 
used misoprostol with herbal tea to induce abortion. Herbal tea was 
used by one mother in the unexposed group.
Misoprostol is a synthetic analog of prostaglandin E
1
 and is used 
in 72 countries(7,10,28). It is approved by the Food and Drug Administra-
tion for use to prevent and treat gastroduodenal ulcers that are indu-
ced by nonsteroidal anti-inflammatories(3,13). The use of misoprostol 
as an abortifacient in countries where abortion is illegal is common 
because of its low cost, easy administration, quick absorption, and 
few side effects(7,10,28). Fonseca et al.(8) reported the use of misoprostol 
in 66% of 2,084 women that attempted to induce an abortion. In Bra-
zil, as in other Latin American countries, misoprostol is the main drug 
used for abortions obtained through the black market(7,8,19,29). The ille-
gal commerce of misoprostol favors drug adulteration and increases 
the risk of subdosage, thus compromising the drug’s efficacy(11,29). 
It is very challenging to identify the specific teratogen that is 
responsible for a congenital abnormality, and women are frequently 
exposed to more than one teratogen during pregnancy(3,5). In addi-
tion, in more than 50% of cases, the environmental agent that caused 
a fetal anomaly is not identified(3). Misoprostol, alcohol, cigarettes, 
marijuana, cocaine, and rubella have been associated with Möbius 
sequence(7,10,13,16-18,20,21,29,30). In the present study, teratogens could be 
identified in most cases (56%), and 9.8% of the mothers were exposed 
to more than one teratogen. Furthermore, an isolated rubella infec-
tion during pregnancy was reported by one of the mothers. 
A previous study of patients with Mobius sequence reported a 
male: female ratio of 1.3:1, which was similar to the results of our 
study(31). In the northeastern region of Brazil, the mothers of children 
with Möbius sequence took 600 to 2,800 µg of misoprostol between 
the fourth and sixth postfertilization week(7). In the present study, 
the mothers of children with Möbius sequence in the southeastern 
region of Brazil reported that they took 400 μg to 2,400 μg of miso-
prostol between the second and fourteenth postfertilization week. 
In previous studies, the profiles of mothers of children with Mö-
bius sequence that used misoprostol included the following charac-
teristics: young age, low income, lower level of education, unstable 
marital status, and precarious access to the public health system(7,10,31). 
The results of the present study agreed with these previous findings; 
the mothers that used misoprostol were generally younger and 
single or divorced. Conversely, the percentages of mothers with low 
education were similar in both groups. 
The main symptoms that were reported by the mothers that used 
misoprostol during pregnancy were cramps and bleeding, which 
are related to the increased uterine muscle contractions induced by 
misoprostol(20). The main recreational drugs used by these mothers 
were cigarettes and alcohol, although there were cases of marijuana 
and cocaine use. In contrast, another study of patients with Möbius 
sequence in northeastern Brazil reported that no cases were expo-
sed to recreational drugs, cigarettes, alcohol, or rubella(7,31). Brazil is a 
continental country with sociodemographic and regional differences 
that possibly justify this discrepancy. Even in developed countries 
Table 1. Sociodemographic profiles of the mothers of patients with Möbius sequence
Misoprostol exposure Total (n=41)
p valueYes (n=19) No (n=22)
n (%) n (%) n (%)
Age at pregnancy (years) 18 (100)* 21 (100)* 39 (100) 0.351
16-20 04 (022)* 05 (024)* 09 (023)
21-25 09 (050)* 06 (029)* 15 (038)
26-30 04 (022)* 07 (033)* 11 (028)
31-35 01 (006)* 03 (014)* 04 (010)
Marital status 17 (100)† 21 (100)* 38 (100) 0.051
Single/divorced 13 (076)* 08 (038)* 21 (055)
Married 03 (018)* 11 (052)* 14 (037)
Stable union 01 (006)* 02 (010)* 03 (008)
Education* 18 (100)* 21 (100)* 39 (100) 0.538
Illiterate 00 (000)* 00 (000)* 00 (000)
Incomplete elementary 02 (011)* 03 (014)* 05 (013)
Complete elementary *3 (017)* 02 (009)* 05 (013)
Complete secondary *8 (044)* 10 (048)* 18 (046)
Complete university *5 (028)* 06 (029)* 11 (028)
*= data were not known for one mother; †= data were not known for two mothers.
Table 2. Gestational signs and symptoms reported by the mothers of 
patients with Möbius sequence 
Symptoms
Misoprostol exposure
p value
Yes (n=19) No (n=22)
n (%) n (%)
Bleeding 09 (56) 07 (044) 0.233
Contractions/pain 08 (62) 05 (039) 0.368
Nausea 09 (41) 13 (059) 0.336
Heartburn 10 (44) 13 (057) 0.469
Vomiting 09 (50) 09 (050) 0.451
Headache 06 (38) 10 (063) 0.283
Fever 04 (80) 01 (020) –
Cutaneous rash 00 (00) 01 (100) –
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with better prenatal care, the lack of knowledge about drugs’ effects 
(therapeutic and recreational) is still responsible for several fetal 
malformations(3,5). 
Maternal exposure to misoprostol during organogenesis (first tri-
mester) does not induce abortion in most cases, but it is frequently 
associated with the appearance of congenital anomalies, such as 
skullcap, cranial nerve and limb defects, arthrogryposis, facial anoma-
lies, and Mobius sequence(6,7,10). The findings of the present study cor-
roborated with previous studies that reported ocular motility defects, 
palpebral ptosis, aberrant tearing, corneal opacification, refractive 
errors, and amblyopia as the main ocular findings in misoprostol-ex-
posed patients during pregnancy(7,27,32,33). 
The most common eye motility pattern in patients with Möbius 
sequence is horizontal gaze paresis that is usually associated with 
marked abduction limitations and variable adduction deficits(32,33). In 
the present series, strabismus was observed in 73.2%, and the most 
frequent form was esotropia (80%). This finding corroborated those 
of another study that found strabismus in 71.7% and 60.0% and eso-
tropia in 39.1% and 40.0% of Brazilian and Italian cases, respectively(31). 
The presence of anomalous tearing is in accordance with the 
theory of focal (nuclear) damage in the lower brainstem during early 
embryogenesis. In our study, the incidence of aberrant tearing was 
Table 3. Exposure to other teratogens during pregnancy as reported by the mothers of patients with Möbius sequence
Other teratogens
Misoprostol exposure
Total (n=41) p value
Yes (n=19) No (n=22) 
n (%) n (%)
Rubella 0 (00) 1 (5) 1 (04) 0.537
Cocaine 2 (11) 0 (0) 2 (05) 0.209
Marijuana 2 (11) 0 (0) 2 (05) 0.209
Cigarettes* 2 (11) 1 (5) 3 (07) 0.444
Alcohol 3 (16) 2 (9) 5 (12) 0.428
*= one or more pack of cigarettes during pregnancy.
Table 4. Congenital ocular malformation distribution according to 
misoprostol exposure during pregnancy
Variables
Misoprostol exposure Total
p value
Yes (n=19) No (n=22) (n=41)
n (%) n (%) n (%)
Strabismus 013 (72)* 17 (77)* 30 (75) 0.387
XT 02 (15) 03 (18)* 05 (17)
ET 11 (85) 13 (76)* 24 (80)
HT 00 (00) 01 (06)* 01 (03)
Lagophthalmos 06 (32) 09 (41)* 15 (37) 0.769
Late-onset tearing 07 (37) 06 (29)* 13 (33) 0.374
Aberrant tears (crocodile tears) 07 (37) 05 (23)* 12 (29) 0.518
OU 04 (57) 03 (60)* 07 (58)
OD 01 (14) 01 (20)* 02 (17)
OS 02 (29) 01 (20)* 03 (25)
Lack of emotional tearing 09 (47) 08 (36)* 17 (42) 0.693
OU 04 (44) 06 (75)* 10 (59)
OD 03 (33) 00 (00)* 03 (18)
OS 02 (22) 02 (25)* 04 (23)
*= data is not known for one Möbius patient.
XT= exotropia; ET= esotropia; HT= hypertropia; OD= right eye; OS, left eye; OU= both eyes.
29%(22). Prior investigations have reported this same symptom in pa-
tients with Möbius sequence in Northeastern Brazil and Italy in 45% 
and 17.9% of children, respectively(13,22). Lagophthalmos was also 
found in more than one-third of the individuals with Mobius sequen-
ce who were assessed in the present study, and this was a higher per-
centage than the percentage described in a previous study (14.3%)(32). 
The main limitations of the current study were the sample size 
and the low prevalence of target outcomes due to Möbius sequence 
being a rare disorder. However, investigations of these children are 
highly relevant for a better understanding of specific risk factors be-
cause there is still much unknown concerning its complex etiology. 
This kind of study may provide insights to better plan preventive 
policies that have been shown to be effective in other contexts. 
In summary, although there were no statistically significant diffe-
rences in the studied variables between the groups, stable marital 
status tended to be more frequent among mothers that did not take 
misoprostol during pregnancy. The exposure to teratogens during 
pregnancy and associated ocular malformations were found in the 
majority of cases, and there were similar distributions of these varia-
bles in both groups. This study highlighted the importance of prenatal 
care as a preventive factor for Möbius sequence, which has significant 
implications for both public health and the patients’ families.
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